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AbstrAct
Introduction Mobile health interventions have the potential 
to promote risk factor management and lifestyle modification, 
and are a particularly attractive approach for scaling across 
healthcare systems with limited resources. We are conducting 
two randomised trials to evaluate the efficacy of text 
message-based health messages in improving secondary 
coronary heart disease (CHD) prevention among patients with 
or without diabetes.
Methods and analysis The Cardiovascular Health And Text 
Messaging (CHAT) Study and the CHAT-Diabetes Mellitus 
(CHAT-DM) Study are multicentre, single-blind, randomised 
controlled trials of text messaging versus standard treatment 
with 6 months of follow-up conducted in 37 hospitals 
throughout 17 provinces in China. The intervention group 
receives six text messages per week which target blood 
pressure control, medication adherence, physical activity, 
smoking cessation (when appropriate), glucose monitoring 
and lifestyle recommendations including diet (in CHAT-DM). 
The text messages were developed based on behavioural 
change techniques, using models such as the information-
motivation-behavioural skills model, goal setting and 
provision of social support. A total sample size of 800 
patients would be adequate for CHAT Study and sample size 
of 500 patients would be adequate for the CHAT-DM Study. 
In CHAT, the primary outcome is the change in systolic blood 
pressure (SBP) at 6 months. Secondary outcomes include a 
change in proportion of patients achieving a SBP <140 mm 
Hg, low-density lipoprotein cholesterol (LDL-C), physical 
activity, medication adherence, body mass index (BMI) and 
smoking cessation. In CHAT-DM, the primary outcome is 
the change in glycaemic haemoglobin (HbA1C) at 6 months. 
Secondary outcomes include a change in the proportion of 
patients achieving HbA1C<7%, fasting blood glucose, SBP, 
LDL-C, BMI, physical activity and medication adherence.
Ethics and dissemination The central ethics 
committee at the China National Center for 
Cardiovascular Disease and the Yale University 
Institutional Review Board approved the CHAT and 
CHAT-DM studies. Results will be disseminated via usual 
scientific forums including peer-reviewed publications.
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strengths and limitations of this study
 ► The trials are the first to investigate the efficacy 
of simple and cost-effective text message-based 
interventions to support management of coronary 
heart disease (CHD) and diabetes mellitus (DM) in 
a large and diverse population in China, and have 
the potential for scaling across healthcare systems 
in resource-constrained settings.
 ► The study addressed the role of text messages in 
managing multiple risk factors in patients with CHD 
or DM, and also targeted high-risk patients with CHD 
with or without diabetes.
 ► The Cardiovascular Health and Text Messaging 
(CHAT) Study and CHAT-DM study are distinguished 
by their relative large sample sizes and culturally 
appropriate, theory-driven text messages, which 
were developed using a behaviour change technique 
and tailored to a specific Chinese patient population.
 ► In contrast to most prior single-centre text 
messaging trials, these two studies are conducted 
at 37 participating sites spread across a large and 
geographically diverse country. The results of the 
studies may be more generalisable.
 ► However, the text messages, though 
semipersonalised (participant’s preferred name, 
smoking status) were not tailored specifically to 
every individual.
2 Huo X, et al. BMJ Open 2017;7:e018302. doi:10.1136/bmjopen-2017-018302
Open Access 
IntroductIon
The benefits of secondary prevention strategies for 
coronary heart disease (CHD) targeting lifestyle modifi-
cation and risk factor management are well established 
worldwide,1 2 however adoption of these strategies is 
suboptimal.3 Smoking, inactivity and obesity are preva-
lent among people with established CHD and control of 
hypertension and diabetes are often suboptimal. Addi-
tionally, medication adherence is poor. Prior studies 
revealed that only three-fourths of all hospitalised patients 
take all medications from their discharge prescriptions 
by 120 days after discharge.4 Furthermore, less than half 
of patients hospitalised with acute myocardial infarction 
(AMI) are adherent to evidence-based medications 1 year 
later, with the greatest gaps in adherence occurring in the 
first 6 months after treatment initiation.5–7 
In lower-income and middle-income countries 
(LMICs), including China, which face a growing burden 
of cardiovascular disease and greater challenges to medi-
cation access for secondary prevention, over two-thirds 
of patients with CHD take no medication.8–10 While high 
medication costs are a barrier,11 there is also limited time 
for education and consultation regarding lifestyle and 
medication management during clinic visits, which tend 
to be very brief.12 13 Therefore, innovative and cost-ef-
fective interventions to enhance adherence are urgently 
needed.
Mobile phones are pervasive and thus can be used to 
deliver interventions that help people adopt secondary 
prevention strategies for CHD in LMICs. They are a 
primary, inexpensive and quick form of communication, 
and are widely used to schedule alerts and reminders. 
In addition, the number of mobile phone users has 
grown exponentially in the past decade worldwide, and 
is projected to reach 4.77 billion by 2017.14 As of August 
2016, China had the largest number of mobile phone 
owners in the world, at 1.3 billion.15 Mobile phones are 
also used across all geographical regions and income 
levels. Due to their ubiquity and convenience, nearly 
200 000 mobile phone messages are sent every second in 
China.16 As such, text messaging has the potential to be 
a scalable and powerful tool to deliver health informa-
tion.17 18
Prior studies of mobile phone text messaging have 
been conducted to improve glycaemic control,19 hyper-
tension,20 medication adherence,21 as well as to promote 
smoking cessation22 and physical activity.23 24 These trials 
have contributed important knowledge, and some, such 
as The Tobacco, Exercise and Diet Messages (TEXT-
ME) trial25 and Trial to Examine Text-based mHealth 
for Emergency department patients with Diabetes 
(TExT-MED)26 suggest that text messaging interven-
tions can influence patient behaviours and improve risk 
profiles. Still, several questions remain about the gener-
alisability of these findings, especially for populations 
from LMICs. Most trials to date have been designed to 
target a single condition; yet patients with cardiovascular 
disease usually manage multiple conditions, requiring 
several lifestyle and treatment recommendations. Addi-
tionally, most studies of text messaging interventions 
have not been grounded in behavioural change tech-
niques (BCTs),27 28 which may influence the efficacy of 
the intervention. Finally, most prior studies have been 
limited to single-site interventions, many of which were 
underpowered and/or limited by selection bias. More 
data are needed to understand whether text messaging 
interventions should be adopted as an effective strategy 
for supporting cardiovascular disease prevention among 
diverse populations from LMICs.29
Accordingly, we designed and conducted the Cardio-
vascular Health And Text Messaging (CHAT) Study and 
CHAT-Diabetes Mellitus (CHAT-DM) Study. The primary 
objective of these two studies is to evaluate the efficacy of 
an automated text message-based intervention, based on 
BCTs, in improving risk factor control and adoption of 
healthy lifestyle behaviours among patients with known 
CHD, with or without DM, who were discharged from 
multiple hospitals throughout China.
MEthods And AnAlysIs
study overview
The CHAT and CHAT-DM studies are multicentre, single-
blind, two-arm, randomised controlled trials of an auto-
mated mobile phone text message-based intervention 
with 6 months of follow-up. Patients were recruited from 
37 hospitals across 17 provinces in China (figure 1, online 
supplementary material 1). The enrolment of participants 
began on 16 August 2016. The two studies were regis-
tered at http://www. clinicaltrials. gov (NCT02888769 and 
NCT02883842) accordingly. We  retrospectively registered 
the trial 7 days later after enrolment of the first patient 
in CHAT Study , beyond the International Committee of 
Medical Journal Editors (ICMJE) recommendations of 
the journal, as we referred to the Food and Drug Admin-
istration (FDA) AA801 public law on the  Clinicaltrials. gov 
website that clinical trials are registered no later than  21 
days  after the first  patient  was enrolled. The recruit-
ment was completed in April 2017, and the last follow-up 
visit is expected to finish in October 2017. All participants 
provided written informed consent at the initial trial visit.
study population
In CHAT, patients were eligible if they had established 
CHD defined as a history of AMI and/or percutaneous 
coronary intervention, access to a mobile phone to read 
and send text messages, and did not have diabetes. In 
CHAT-DM, patients were eligible if they had a history of 
documented CHD (as defined in CHAT) and diabetes, 
and had access to a mobile phone to read and send text 
messages. In both studies, patients were excluded if they 
could not read or send text messages, had cognitive or 
communication disorders, or could not provide informed 
consent. A ‘screening log’ of basic demographic informa-
tion and reasons for not participating in patients deemed 
ineligible or declined to participate has been recorded. 
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Figure 1 Geographical distribution of sites in the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-
Diabetes Mellitus (DM) Study.
We recruited patients who had been hospitalised with 
CHD, with or without DM, and had medical records with 
definite discharge diagnoses available. The diagnoses of 
CHD and DM given by local physicians were adjudicated 
centrally, based on review of the patients’ medical charts, 
which were sent to the China National Center for Cardio-
vascular Disease (NCCD).
randomisation and blinding
Participants were randomly allocated to either the inter-
vention or the control arms in a 1:1 ratio using a comput-
erised randomisation system. In order to achieve a 
balance of participants’ characteristics in both arms, we 
employed a stratified randomisation approach, based on 
age, gender, AMI history, education degree and medical 
insurance type within each study. Researchers, statisticians 
and clinic staff were blinded to treatment allocation.
trial intervention
Participants in the intervention groups of the CHAT 
and CHAT-DM studies receive text messages about CHD 
risk factor modification for 6 months as well as standard 
treatment (described below). The control group in both 
studies receive two thank you text messages without risk 
factor modification support each month as well as stan-
dard treatment. A training session was held by research 
staff on enrolment to ensure that all participants were 
capable of receiving, reading and sending text messages 
on their mobile phones. Prior to commencement, a 
test message was sent to each participant to confirm the 
phone number and that the system was working effec-
tively. Whether the test messages had reached the patients 
would be recorded by local study staff, and if patients did 
not receive messages, local study staff would confirm and 
update the correct phone number. Participants were 
also informed that they could withdraw from the study 
by responding to a text message with a specific character. 
Researchers at NCCD could monitor the status of text 
message delivery, review responses sent by participants 
and manage withdrawal via a customised software plat-
form. For instance, logs were kept to assess the propor-
tion of text messages successfully delivered, the exact 
time of messages being sent and the reasons for those that 
failed to be sent.
chAt and chAt-dM intervention development
A bank of 550 text messages (280 in CHAT and 270 in 
CHAT-DM) was developed by a multidisciplinary team of 
cardiologists, endocrinologists, psychologists, nurses and 
public health researchers using a three-phase systematic 
and iterative approach (figure 2). In the CHAT Study, 
text messages are categorised into five groups: (1) general 
education on CHD and AMI, (2) medication adherence, 
(3) blood pressure control, (4) physical activity and (5) 
smoking cessation. The text messages in the CHAT-DM 
Study cover a range of diabetes self-management topics 
including: (1) general education on CHD and DM, 
(2) medication adherence, (3) glucose monitoring and 
control, (4) blood pressure control, (5) physical activity 
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Figure 2 Text development process. AHA, American Heart Association; BCT, behavioural change techniques; CHAT, 
Cardiovascular Health And Text Messaging; CVD, Cardiovascular Disease; DM, diabetes mellitus. 
and (6) lifestyle recommendations such as diet and foot 
care. All text messages are in Chinese, and each text 
message is less than 70 Chinese characters, which would 
be equivalent to a 140–160-character message in English.
Phase 1: Approach to developing text messages
Text messages were originally drafted by members of the 
research team in Chinese based on current guidelines30–32 
and standards of care pertaining to cardiovascular 
health and diabetes care. All messages were grounded in 
BCTs previously used to develop short health messages, 
providing information, goal setting, motivation, social 
support and stress management advice.33 In order to 
strengthen designing and reporting of theory-based 
BCT interventions, we took into account the two recent 
BCT taxonomies by Michie and colleagues.34 35 Efforts 
were devoted to selecting the BCTs most applicable 
to the Chinese cultural context and compatible with 
Chinese beliefs and values (table 1). For example, some 
text messages applied traditional Chinese aphorisms, 
chengyu and catchy rhyme schemes in order to make 
them more acceptable to patients. As another example, 
in designing text messages that were motivating, espe-
cially in challenging situations, the multidisciplinary 
group felt that Chinese people tend to prefer more direct 
and structured counselling instructions rather than 
indirect and insight-oriented approaches (a category of 
psychotherapeutic approaches that promote individuals’ 
adaptive behaviour and course of action in life through 
understanding their internal motivation);36 as such, text 
messages were written to provide practical approaches 
and real life examples instead of abstract theories.37 38 
Social and family oriented goals were used more often 
than individual achievement to help improve health 
behaviours, consistent with cultural norms in China.39 40 
These messages were sent to experts in BCTs and coun-
selling for review and were used as examples to draft 
the initial bank of 550 text messages. Once drafted, all 
messages were reviewed, critiqued and revised within the 
internal research team.
Phase 2: Expert review
An expert panel made up of clinicians and academics 
reviewed each round of text message drafts with a 
different focus in each iteration. First, clinical experts 
(cardiologists, endocrinologists and psychologists) 
considered the accuracy, clarity and practical usefulness 
of each text message. Second, 21 messages from all cate-
gories in the CHAT and CHAT-DM Studies text banks 
were randomly selected and translated into English 
by bilingual researchers. Experts in the fields of cardi-
ology, endocrinology, epidemiology, psychology and 
behavioural science in the USA reviewed them and 
provided suggestions for further refinement. Finally, 
Chinese researchers and a linguist reviewed all 550 text 
messages, further refined the language, and paid special 
attention to the cultural meaning of all text messages to 
ensure better understanding among the targeted popu-
lation (elderly Chinese patients with cardiovascular 
disease, with and without diabetes). Once feedback from 
the experts was addressed, the text bank was updated 
and prepared for user testing.
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Table 1 Behaviour change techniques used in message development and example messages
Behaviour change 




General information about 
behavioural risk
The way you cook can impact your health as well. Steaming, boiling 
and sautéing are better ways to cook than deep-frying and pan-frying. 
Cooking in less oil is a healthy alternative.
Prompt barrier 
identification
Identify barriers to perform the 
behaviour and plan ways of 
overcoming them
Taking diabetes medications and injecting insulin regularly can help 
control your blood sugar. Forgetting to take your medication? Try to set a 
repeating alarm on your cellphone to remind you to take your medication 
or insulin injection.
Set graded tasks Set easy tasks, and increase 
difficulty until target behaviour is 
reached
Have you been finding it hard to quit smoking? In the beginning things are 
always hard. You can use a schedule to gradually reduce the number of 
cigarettes you smoke. For example, you may try going from 20 cigarettes 
to 15 per day for a week.
Provide instruction Tell the person how to perform 
a behaviour and/or preparatory 
behaviours
If you experience symptoms of angina (severe chest pain), place one 
nitroglycerin tablet under your tongue. Sit, stay calm and rest if you ever 
forget medications while going out. If angina symptoms are not relieved 




The person is asked to keep a 
record of specified behaviour(s)
A cold or diarrhoea will make your blood sugar levels rise, so monitor your 
glucose more frequently when you are sick. If you are using insulin, test 
your blood glucose six to eight times a day, keep a blood glucose log and 
share it with your health providers.
Prompt practice Prompt the person to rehearse and 
repeat the behaviour or preparatory 
behaviours
As an old Chinese saying goes, ‘It takes more than one cold day for a 
river to freeze three feet deep; ice in the river takes a long time to melt.’ 
Similarly, cerebrovascular disease requires long-term prevention and 
treatment. Remember to take your medications as prescribed!
Plan social support 
or social change
Prompt consideration of how others 
could change their behaviour 
to offer the person help or 
(instrumental) social support
Quitting smoking on your own can be difficult. Tell your friends and family 
when you are quitting so that they will stop giving you cigarettes. Support 
and encouragement from your loved one can be helpful as well.
Stress management May involve a variety of specific 
techniques (eg, progressive 
relaxation) that do not target the 
behaviour but seek to reduce 
anxiety and stress
Relaxation is something we need to learn and practice. Listening to music, 
reading or talking to friends and family can ease stress.
Motivational 
interviewing
Prompt the person to provide 
self-motivating statements and 
evaluations of their own behaviours 
to minimise resistance to change
Did you smoke less today than you did yesterday or days before? If you 
did reduce the amount of cigarettes, it is something worth celebrating. We 
are sure that you have put a lot of effort into quitting. Keep up the good 
work and you can make a difference!
Phase 3: user testing and pilot study
For user testing, 19 randomly selected text messages 
from the finalised text bank in the CHAT and CHAT-DM 
Studies were distributed to 39 individuals with CHD 
(with or without diabetes) for feedback. Likert-type items 
in a survey were used to assess usefulness and ease of 
understanding of the text messages. Open-ended ques-
tions were asked to obtain suggestions for improvement 
from participants. In total, 92.4% (582/630) rated the 
messages as easy to understand and 93.2% (587/630) 
rated the messages as useful. All 550 text messages were 
further modified based on feedback from user testing. 
Results of the scores for the message categories in this 
phase are summarised in table 2.
Next, the refined text message banks underwent pilot 
testing to evaluate the efficacy of the message delivery 
system and quality of the user experience. A customised 
software programme sent messages through a gateway 
interface, allowing them to be sent to all individuals’ 
mobile phones free of charge and at a bulk-rate cost 
(¥0.1 per message, or US$0.01 USD) to the research 
team. Participants from the user testing were enrolled in 
the pilot testing after providing written informed consent 
(n=33). For the pilot study, messages drawn from the 
entire text bank were sent to participants. At the end of 
the 1-month pilot study, 30 participants reported their 
experience of receiving messages and commented on 
frequency, timing, content and potential impact of text 
messages. Minor changes were made to the text message 
bank following the pilot study based on this feedback.
Frequency and timing of text message delivery
Each participant in the intervention group of the CHAT 
and CHAT-DM Studies receives six text messages per 
week, randomly selected by the software system, across 
a 6-month timeframe. The messages are sent at one of 
three random times (9:00, 12:00 or 4:00), during week-
ends and weekdays (excluding Monday to give people 
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Table 2 Survey scores for various message categories in user test
Strongly agree or 
agree (%) Neutral (%)
Strongly disagree or 
disagree (%)
General health messages
  Information easy to understand (n=142) 130 (91.6) 6 (4.2) 6 (4.2)
  Information was useful (n=142) 129 (90.9) 9 (6.3) 4 (2.8)
Hypertension
  Information easy to understand (n=181) 168 (92.8) 7 (3.9) 6 (3.3)
  Information was useful (n=181) 169 (93.4) 6 (3.3) 6 (3.3)
Medication adherence
  Information easy to understand (n=149) 134 (89.9) 10 (6.7) 5 (3.4)
  Information was useful (n=149) 137 (92.0) 10 (6.7) 2 (1.3)
Physical activity
  Information easy to understand (n=116) 109 (93.9) 6 (5.2) 1 (0.9)
  Information was useful (n=116) 111 (95.7) 4 (3.4) 1 (0.9)
Smoking cessation
  Information easy to understand (n=42) 41 (97.6) 1 (2.4) 0 (0)
  Information was useful (n=42) 41 (97.6) 0 (0) 1 (2.4)
a break). The text messages were semipersonalised with 
participants' preferred name at the beginning of some 
messages, and the smoking status being the second factor 
considered for personalisation. In the CHAT Study, 
participants receive two general education messages 
on CHD (one if an active smoker), two blood pressure 
control messages, one medication adherence message 
and one physical activity message per week. Smokers 
receive one smoking cessation message per week. Partic-
ipants in the CHAT-DM intervention group receive one 
general message, one blood pressure related message, 
one glucose control message, one lifestyle modification 
message, one medication adherence message and one 
physical activity message per week (table 3).
Initially, a test message was sent to each participant 
to ensure that the correct mobile phone number had 
been recorded and the system was functioning appropri-
ately. All participants received a personalised welcome 
message, a follow-up reminder and a birthday greeting 
while enrolled in the study. Most of the text messages were 
developed to be unidirectional and participants are not 
anticipated to reply, however bidirectional text messages, 
checking on medication adherence and blood pressure/
glucose level measurements are sent at weekly intervals to 
evaluate patient engagement. Throughout the 6-month 
follow-up, research staff call participants if they do not 
respond for two consecutive weeks, and only one call is 
made per patient during the intervention period, so as 
not to confound the intervention.
Procedures for data collection and management
Data collection
Basic and contact information (ID number, address and 
phone number), anthropometric data (waist circumfer-
ence, height and weight), resting blood pressure, heart 
rate, ambulatory blood pressure, and information on 
socioeconomic status, risk factor control and current 
medications were collected at baseline at hospital recruit-
ment sites. Detailed information on patient outcomes 
(hospitalisations, discharge diagnoses, etc) was also 
collected during the survey and hospital records or 
death certificates obtained where necessary for adju-
dication. Additional assessments of baseline medica-
tion adherence, physical activity (International Physical 
Activity Questionnaire: IPAQ),41 42 Cardiovascular disease 
(CVD)-specific health status (Seattle Angina Question-
naire: SAQ),43 health status (EuroQol five-dimensional 
questionnaire: EQ-5D)44 and smoking status were also 
conducted in person. Lastly, blood and urine samples 
were collected for local lab tests and eventual transfer to 
the core lab in Beijing at the biobank of NCCD. To ensure 
the standardisation and accuracy of the sample analysis 
results, we developed standard operating procedures 
and trained local study researchers repeatedly regarding 
samples collection, separation, storage and transfer 
process. Blood tests, including low-density lipoprotein 
cholesterol (LDL-C), glycaemic haemoglobin (HbA1C) 
and fasting blood glucose (FBG) will be analysed at the 
central laboratory. Research staff would collect the above 
information again as listed in table 4 at the follow-up 
visit. We conducted on-site monitoring of recruitment, 
physical measurements, sample collection and document 
completeness (eg, informed consent) by trained staff 
from NCCD to ensure the quality of data collection.
data management
A proprietary software platform was developed by the 
study Information Technology (IT) team for use in 
sending text messages to participants. The platform is 
capable of sending tailored and semipersonalised text 
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Table 4 Baseline and follow-up data collection
Information Baseline 6 months
Basic and contact information √ √
Physical examination: BP, HR, waist 
circumference, weight, height
√ √
Ambulatory blood pressure √ √
Outcome (death, myocardial infarction, 
angina, stroke, revascularisation, etc)
√ √
Hospitalisations √ √
Current medications √ √
Medication adherence √ √
Physical activity (International Physical 
Activity Questionnaire)
√ √
CVD functional status (Seattle Angina 
Questionnaire)
√ √
Health status (EuroQol five-dimensional 
questionnaire)
√ √
Socioeconomic status √ √
Risk factors control √ √
Urine cotinine/nicotine test √ √
Blood and urine samples for core lab and 
local test
√ √
BP, blood pressure; CVD, cardiovascular disease; HR, heart 
rate. 
messages to participants and also recording responses. 
Additionally, this web-based platform is used to monitor 
project progress, as well as provide management support 
for hospitals, staff members, equipment and sampling 
collection and transfer. Trained medical staff members 
fill out predesigned onscreen case report forms at each 
site, and data are then securely transmitted to the central 
server through automatic electronic transfer. To ensure 
the reliability and validity of the data, continuous checks 
are run to ensure that data being entered are complete 
and meet predefined data formats and ranges. The data-
base is regularly backed up and password protected so 
that only a limited number of approved staff members 
can access the data. In order to ensure the confidentiality 
of all personal information, data confidentiality policies 
of NCCD on data collection, storage and analysis have 
been strictly imposed.
outcomes
In the CHAT Study, the primary outcome is the change in 
systolic blood pressure (SBP) after 6 months. Secondary 
outcomes include a change in proportion of patients 
achieving a SBP <140 mm Hg, change in proportion of 
non-smokers, change in medication adherence , as well 
as change in plasma mean level of LDL-C, change in level 
of body mass index (BMI) and change in level of physical 
activity. Exploratory outcomes include the prognosis of 
the patients at 6 months, such as death, non-fatal myocar-
dial infarction, stroke and any rehospitalisation, as well as 
health status measured by SAQ and EQ-5D.
In the CHAT-DM Study, the primary outcome is the 
change in glycaemic HbA1C as measured by the central 
blood sample. Secondary outcomes include a change in 
proportion of patients achieving HbA1C<7%, change in 
medication adherence, as well as change in mean level 
of FBG, SBP, LDL-C, BMI and physical activity. Explor-
atory outcomes include prognosis of patients at 6 months, 
including death, non-fatal myocardial infarction, stroke 
and any rehospitalisation, as well as health status (SAQ 
and EQ-5D).
Blood pressure is measured on the right upper arm 
after 5 min of rest in a seated position using an elec-
tronic blood pressure monitor (Omron HEM-7111; 
Omron Corporation, Dalian, China). Two measure-
ments are taken and the mean value is calculated. If the 
difference between the two SBP or diastolic blood pres-
sure readings is larger than 5 mm Hg, a third measure-
ment is done, and the mean value of the three readings 
is calculated.45 46 HbA1C is determined using a high-per-
formance liquid chromatography technique with 
ADAMS A1CHA-8180 (ARKRAY, Japan). BMI is calcu-
lated by dividing weight in kilograms by height in metres 
squared. Physical activity is measured in metabolic 
equivalents of task per minute per week, using the short 
version of IPAQ.41 42 Smoking status is determined using 
either self-reported smoking status or urine-cotinine 
testing strip with a cut-off of 200 ng/mL cotinine (COT 
Cotinine Test Colloidal Gold; Hangzhou Clongene 
Biotech, China).47 48 Quality of life is measured using 
the short version of SAQ43 and EQ-5D.44 Local study 
staff obtained information of baseline hospitalisation, 
readmissions to hospitals and death during the patient’s 
interview, with medical records, death certificates or 
death records collected as supporting documents. If 
the patient died at home without any evidentiary mate-
rial, a structured summary of death conversation with 
family members would be reported. All information 
was sent to NCCD for central adjudication according to 
prespecified criteria by trained clinicians. If the patient 
was rehospitalised in other hospitals, for example, the 
study investigators will contact the specific hospital, copy 
those medical records and transmit them to NCCD as 
required.
statistical analysis
Intervention evaluation will be carried out on an inten-
tion-to-treat basis. Values of analysed parameters at 
baseline between intervention group and control group 
will be compared using Student’s t-tests for continuous 
variables or χ2 tests for categorical variables according 
to the analysis plan. Mann-Whitney U tests will be used 
where continuous data are not normally distributed. 
The primary analysis will employ analysis of covariance 
with baseline values of the analysed end points used as 
covariates when appropriate. The mean change of each 
risk factor will also be compared between groups. In all 
analyses, 95% CIs and two-sided P values will be reported. 
We will conduct a prespecified second analysis with 
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adjustment for patient characteristics as well as subgroup 
analyses based on age, sex, education, smoking status and 
tertile levels of end points.
All sample size calculations in both studies are for 80% 
power and 0.05 (one-sided) level of significance, allowing 
for 20% dropout rate during follow-up. In the CHAT Study, 
we estimate a mean SBP level of 132 mm Hg (SD, 18 mm 
Hg) in the study population according to the report of 
previous studies,49 and assume an absolute difference in 
SBP changes of 5 mm Hg at 6 months from baseline in the 
intervention group and no change in the control group. 
A total sample size of 800 patients would be adequate 
to detect this difference in SBP changes between two 
groups even when considering the potential non-com-
pliance to the intervention. In the CHAT-DM Study, we 
assume a mean HbA1C level of 7.2% (SD, 1.6%) based on 
data from studies involving similar populations50 51 and 
supposed a 0.5% absolute difference in HbA1C changes 
in treatment group and no change in the control group 
at 6 months from the baseline. A total sample size of 500 
patients is adequate to detect this difference in HbA1C 
change between two groups even when considering the 
potential non-compliance to the intervention. The trial 
results will be reported in accordance with the Standard 
Protocol Items: Recommendations for Interventional 
Trials (SPIRIT) checklists.
dIscussIon
The CHAT and CHAT-DM Studies aim to assess the efficacy 
of an innovative intervention for improving secondary 
prevention of CHD by using simple and cost-effective text 
messaging technology among patients with known CHD, 
with or without DM, throughout China. To the best of our 
knowledge, these two trials are the first to investigate the 
efficacy of text messages to support management of CHD 
and DM among a large population in China, and may set 
a model of such interventions that can be leveraged to 
improve risk factor management in resource-constrained 
settings.
The CHAT and CHAT-DM Studies have several 
strengths. While prior studies evaluated the effectiveness 
of mobile phone text messaging to improve single indi-
vidual health behaviours, very few trials have addressed 
the role of text messages in managing multiple risk 
factors in patients with CHD or DM, which is a reality for 
many patients. Patients with CHD and DM often have 
multiple risk factors, yet the care for these conditions is 
often fragmented. Targeting multiple risk factors concur-
rently instead of managing a single risk factor may be 
more efficient and impactful on disease management as 
this strategy is more patient-centred than disease-centred, 
and have a greater likelihood of improving risk factor 
control and cardiovascular outcomes.52 53 Additionally, 
there is currently little evidence about the effectiveness 
of such interventions for high-risk patients with CHD and 
diabetes.
The CHAT and CHAT-DM Studies are further distin-
guished by their large sample sizes and culturally appro-
priate, theory-driven text messages. Most text message 
intervention studies that have focused on health 
behaviour or diabetes management have had sample sizes 
ranging from 18 to 357 participants.54 CHAT has a sample 
size of around 800 while the sample size of CHAT-DM is 
around 500. It is noteworthy that CHAT is the first study 
using theory-based text messaging as a method of delivery 
for behaviour change of patients with CHD in China. Data 
from other text messaging intervention studies suggest 
that text messaging programmes achieved better results 
when message content is theory-based,54 however, few 
text messaging studies specified a theoretical rationale. 
Further, text messages were tailored to a specific Chinese 
patient population. Studies have found that the majority 
of Chinese adults prefer learning by following directive 
rules and guidelines,55 and practical counselling instruc-
tions were provided through text messages to help them 
better modify health behaviours. Apart from this, the text 
message language was designed to be plain and easy to 
memorise, consistent with Chinese cultural features such 
as aphorism, chengyu and catchy rhyme schemes, making 
it more acceptable to patients.
The two studies have several additional strengths. In 
contrast to most prior single-centre text messaging trials, 
these two studies are conducted at 37 participating sites 
spread across a large and geographically diverse country. 
These results may be more generalisable. Moreover, our 
research team devoted significant attention to quality 
data collection, including rigorous on-site monitoring 
of questionnaire answers, samples collection and data 
management. Furthermore, an evaluation of the accept-
ability and feasibility of our text message-based interven-
tion will provide further important evidence to inform 
future studies, particularly with regards to optimising text 
content, text frequency and the overall user experience.
Our study also has some potential limitations. First, 
medication adherence and physical activity are measured 
by self-report, which carries the possibility of recall bias 
and social desirability bias. However, we believe that any 
such bias would be balanced across the treatment and 
control groups, and IPAQ have been validated and are 
widely used in measuring these metrics. Second, the 
text messages, though semipersonalised (participant’s 
preferred name, smoking status) were not tailored specif-
ically to every individual.
The CHAT and CHAT-DM Studies have important 
public health implications. As low cost, non-pharmacolog-
ical interventions, the CHAT and CHAT-DM Studies may 
serve as important models for patient-centred, evidence-
based public health interventions. LMICs, including 
China, face challenges with huge burdens of CVD and 
DM, limited health resources, and geographically and 
culturally diverse patient populations, making them the 
ideal places to conduct such studies. Still, high levels of 
mobile phone ownership across countries and income 
levels signal a promising new avenue for clinical research 
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and that it may be possible to scale effective mobile health 
interventions for delivery to large populations in the 
coming years. Text messaging interventions are simple, 
cost-effective and incur minimal, if any, risk. Hence, if 
our interventions are effective in improving risk factor 
control and lifestyle modification, large-scale implemen-
tation could benefit a diverse population in China.
In conclusion, the CHAT and CHAT-DM Studies are 
multicentre, randomised controlled trials that are being 
conducted at 37 hospitals, and will thoroughly test the 
efficacy of text messages to support secondary prevention 
for CHD and DM in China. These two trials target high-
risk patient populations with a culturally sensitive, scalable 
and cost-effective intervention, and have the potential to 
provide novel insights into disease management and can 
be scaled up to improve health in a significant proportion 
of patients in the future.
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